An agreement was signed between the Cabinet of Ministers of Kyrgyzstan and BIOPHARMAX BV on the implementation of Life Sciences Industrial Park investment project. The Ministry of Economy and Commerce reported.
The document provides for the construction of a pharmaceutical complex, including a plant for the production of insulin and other medicines that will meet the requirements of the good manufacturing practice rules of the Eurasian Economic Union. In addition, laboratories, a training center and storage facilities will be built. All facilities will be located on the territory of Kyrgyzstan.
«Thanks to the implementation of the project, insulin and other medicines will be produced in the country, most of which are included in the National List of Essential Medicines of the Kyrgyz Republic, as well as drugs that are not produced in the country. In addition, construction of the modern pharmaceutical complex will have a multiplier effect for attracting new investors, given the rapid development of technologies in the pharmaceutical sector,» the Ministry of Economy stressed.
